Placeholder

LabCentral Houses Scientific Visionaries
Engaged in Early-Stage Research

Dyno Therapeutics

Dyno Therapeutics develops technologies for safe, efficient and targeted in vivo delivery of new gene therapies and genome editing therapies. Our data-driven approach combines next-generation DNA synthesis of millions of AAV capsids with high-throughput sequencing and machine learning.

 

  • Eric Kelsic, PhD Founder & CEO
  • Alan Crane, MBA Founder & Executive Chair
  • Shimyn Slomovic, PhD Founder & Head of Molecular & Synthetic Biology
  • Adrian Veres Scientific Founder
  • Sam Sinai Scientific Founder
  • George Church, PhD Scientific Founder